Work

Sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) patients ≥80 years-old: Data from PROCEED.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.64

Authors: Chadi Nabhan, A. Oliver Sartor, Matthew R. Cooperberg, Andrew J. Armstrong, Jeffrey L. Vacirca, Raoul S. Concepcion, William R. Berry, Manish Dhawan, Ronald Tutrone, Andrew Sandler, Candice McCoy, James Boyd Whitmore, Robert Claude Tyler, Celestia S. Higano

Institutions: University of Chicago, Tulane University, University of California, San Francisco, Duke University, Urology Associates, CHRISTUS Highland Medical Center, Chesapeake Urology Associates, Dendreon (United States), Seattle Cancer Care Alliance, University of Washington

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590282175

Cites:

Cited by: 5

Related to: 10